Effect of aspirin dosage and enteric coating on platelet reactivity

American Journal of Cardiology

Volumn 80, Issue 2, 1997, Pages 189-193

  Feng, Dali ^a   McKenna, Carol ^a   Murillo, Jaime ^a   Mittleman, Murray A ^a   Gebara, Otavio C ^a   Lipinska, Izabella ^a   Muller, James E ^a   Tofler, Geoffrey H ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; TREADMILL;

6-KETOPROSTAGLANDIN F1 ALPHA; ADOLESCENT; ADULT; ASPIRIN; DOUBLE-BLIND METHOD; HUMANS; MALE; PLATELET AGGREGATION; TABLETS, ENTERIC-COATED;

EID: 0030752399     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00316-0     Document Type: Article

References (30)

1. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1967;194:927-929.
2. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985;57:1170-1173.
3. Fox E, Kuo J, Tilling L, Ulrich C. Comparing repeated measurement of the same individuals. In: The SigmaStat Statistical Software User's Manual. vol. 8. San Rafael, CA: Jandel Scientific, 1994:1-76.
4. Fox E, Kuo J, Tilling L, Ulrich C. Comparing two or more groups. In: The SigmaStat Statistical Software User's Manual. Vol. 7. San Rafael, CA: Jandel Scientific, 1994:1-73.
5. The Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-135.
6. Elwood PC. Aspirin in the prevention of myocardial infarction: current status. Drug 1984;28:1-5.
7. Lewis HD Jr, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med 1983;309:396-403.
8. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990;336:827-830.
9. ISIS2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS2. Lancet 1988;2:349-360.
10. Patrignani P, Filabozzi P, Patrono C. Selective, cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982;69:1366-1372.
11. Hanley SP, Bevan J, Cockbill SR, Heptinstall S. A regimen for low-dose aspirin? Br Med J 1982;285:1299-1302.
12. 2 but not of systemic prostacyclin by controlled release aspirin. N Engl J Med 1991;325:1137-1141.
13. 2 and prostacyclin. Stroke 1992;23:1400-1403.
14. Masotti GG, Galanti L, Poggesi R, Abbate R. Differential inhibition of prostacyclin production and platelet agggregation by aspirin. Lancet 1979:1213-1216.
15. Lejeune L, Fattet M, Degos JD. Aspirin dose, bleeding time, platelet adhesion and aggregation in cerebral thrombosis. Int J Clin Pharmacol Ther Toxicol 1988;26:237-242.
16. O'Brien JR. How much aspirin? Thromb Haemost 1990;64:486.
17. Caterina RD, Giannessi D, Boem A, Bernini W, Battaglia D, Michelassi C, Dell' Amico F, L' Abbate A, Patrignani P, Patrono C. Equal antiplatelet effects of aspirin 50 or 324 mg/day in patients after acute myocardial infarction. Thromb Haemost 1985;54:528-532.
18. Buerke M, Pittroff W, Meyer J, Darius H. Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses. Am Heart J 1995;130:465-472.
19. Dabaghi SF, Kamat SG, Payne J, Marks GF, Roberts R, Schafer AI, Kleiman NS. Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects. Am J Cardiol 1994;74:720-723.
20. Paccioretti MJ, Pharm D, Block LH. Effects of aspirin on platelet aggregation as a function of dosage and time. Clin Pharmacol Ther 1980;27:803-809.
21. Moncada S, Gryglewski R. Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976;263:663-665.
22. Vane JR, Anggard E, Botting EN. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
23. Rowland M, Riegelman S, Harris PA, Shokoff SD. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci 1972;61:379-385.
24. Pederson AK, FitzGerald GA. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. N Engl J Med 1984;331:1206-1211.
25. Weksler BB, Pett SB, Alonso D, Richard RC, Stelzer P, Subramanian V, Tack-Goldman K, Gay WA. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Engl J Med 1983;308:800-805.
26. 2 in whole blood after aspirin administration in human subjects. J Am Coll Cardiol 1984;4:806-811.
27. α in humans in response to a standardized vascular injury and the influence of aspirin. Circulation 1989;79:29-38.
28. Hart RG, Harrison MJG. Aspirin wars: The optimal dose of aspirin to prevent stroke. Stroke 1996;27:585-587.
29. Husted SE, Nielsen HK, Krusell LR, Faergeman O. Acetylsalicylic acid 100mg and 1000mg daily in acute myocardial infarction suspects: a placebo-controlled trial. J Intern Med 1989;226:303-310.
30. Hoffman W, Forster W. Two year Cottbus reinfarction study with 30 mg aspirin per day. Prostaglandins Leukot Essent Fatty Acids 1991;44:159-169.